Approval · Notice of Compliance 17837 · 2016
VIMIZIM: Notice of Compliance 17837
Issued March 3, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17837
- Date
- March 3, 2016
- Company
- Biomarin International LimitedRingaskiddy, Cork, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIMIZIM | Not yet assigned | — |
Medicinal ingredients
- ELOSULFASE ALFA 1 MG per ML